LYTIR

Insider · SEC Form 4 · Director

Keith A. Jones

Filed with the SEC as Jones Keith Anthony; the order above is the one the filer's own signature uses.

In the 12 months to Nov 8, 2026, on the open market: bought $30K of HUMA. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $30K in total; Insider sales: $0 in total.Aug: Insider purchases $25KSep: Insider purchases $6KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $30KInsider sales below: $0
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. HUMABought: Humacyte, Inc. Sep 14, 2026 10,000 shares filed Sep 15, 2026 50,000 shares held directly after, as filed filing $6K
  2. HUMABought: Humacyte, Inc. Aug 20, 2026 10,000 shares filed Aug 21, 2026 40,000 shares held directly after, as filed filing $7K
  3. HUMABought: Humacyte, Inc. Aug 17, 2026 30,000 shares filed Aug 19, 2026 30,000 shares held directly after, as filed filing $18K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.